Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta‐Analysis

Background Sex differences in the management of cardiovascular disease have been reported in secondary care. We conducted a systematic review with meta‐analysis of systematically investigated sex differences in cardiovascular medication prescription among patients at high risk or with established ca...

Full description

Bibliographic Details
Main Authors: Min Zhao, Mark Woodward, Ilonca Vaartjes, Elizabeth R. C. Millett, Kerstin Klipstein‐Grobusch, Karice Hyun, Cheryl Carcel, Sanne A. E. Peters
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.014742
_version_ 1818775651636740096
author Min Zhao
Mark Woodward
Ilonca Vaartjes
Elizabeth R. C. Millett
Kerstin Klipstein‐Grobusch
Karice Hyun
Cheryl Carcel
Sanne A. E. Peters
author_facet Min Zhao
Mark Woodward
Ilonca Vaartjes
Elizabeth R. C. Millett
Kerstin Klipstein‐Grobusch
Karice Hyun
Cheryl Carcel
Sanne A. E. Peters
author_sort Min Zhao
collection DOAJ
description Background Sex differences in the management of cardiovascular disease have been reported in secondary care. We conducted a systematic review with meta‐analysis of systematically investigated sex differences in cardiovascular medication prescription among patients at high risk or with established cardiovascular disease in primary care. Methods and Results PubMed and Embase were searched between 2000 and 2019 for observational studies reporting on the sex‐specific prevalence of aspirin, statins, and antihypertensive medication prescription, including beta blockers, calcium channel blockers, angiotensin‐converting enzyme inhibitors, and diuretics, in primary care. Random effects meta‐analysis was used to obtain pooled women‐to‐men prevalence ratios for each cardiovascular medication prescription. Metaregression models assessed the impact of age and year on the findings. A total of 43 studies were included, involving 2 264 600 participants (28% women) worldwide. Participants’ mean age ranged from 51 to 76 years. The pooled prevalence of cardiovascular medication prescription for women was 41% for aspirin, 60% for statins, and 68% for any antihypertensive medications. Corresponding rates for men were 56%, 63%, and 69% respectively. The pooled women‐to‐men prevalence ratios were 0.81 (95% CI, 0.72–0.92) for aspirin, 0.90 (95% CI, 0.85–0.95) for statins, and 1.01 (95% CI, 0.95–1.08) for any antihypertensive medications. Women were less likely to be prescribed angiotensin‐converting enzyme inhibitors (0.85; 95% CI, 0.81–0.89) but more likely with diuretics (1.27; 95% CI, 1.17–1.37). Mean age, mean age difference between the sexes, and year of study had no significant impact on findings. Conclusions Sex differences in the prescription of cardiovascular medication exist among patients at high risk or with established cardiovascular disease in primary care, with a lower prevalence of aspirin, statins, and angiotensin‐converting enzyme inhibitors prescription in women and a lower prevalence of diuretics prescription in men.
first_indexed 2024-12-18T11:00:26Z
format Article
id doaj.art-b5511a7a3f094403b8c3bf7f4dd7115f
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-12-18T11:00:26Z
publishDate 2020-06-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-b5511a7a3f094403b8c3bf7f4dd7115f2022-12-21T21:10:14ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802020-06-0191110.1161/JAHA.119.014742Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta‐AnalysisMin Zhao0Mark Woodward1Ilonca Vaartjes2Elizabeth R. C. Millett3Kerstin Klipstein‐Grobusch4Karice Hyun5Cheryl Carcel6Sanne A. E. Peters7Julius Global Health Julius Centre for Health Sciences and Primary Care Utrecht Medical Centre Utrecht University Utrecht NetherlandsThe George Institute for Global Health University of Oxford United KingdomJulius Global Health Julius Centre for Health Sciences and Primary Care Utrecht Medical Centre Utrecht University Utrecht NetherlandsThe George Institute for Global Health University of Oxford United KingdomJulius Global Health Julius Centre for Health Sciences and Primary Care Utrecht Medical Centre Utrecht University Utrecht NetherlandsFaculty of Medicine and Health Westmead Applied Research Centre University of Sydney AustraliaThe George Institute for Global Health University of New South Wales Sydney AustraliaJulius Global Health Julius Centre for Health Sciences and Primary Care Utrecht Medical Centre Utrecht University Utrecht NetherlandsBackground Sex differences in the management of cardiovascular disease have been reported in secondary care. We conducted a systematic review with meta‐analysis of systematically investigated sex differences in cardiovascular medication prescription among patients at high risk or with established cardiovascular disease in primary care. Methods and Results PubMed and Embase were searched between 2000 and 2019 for observational studies reporting on the sex‐specific prevalence of aspirin, statins, and antihypertensive medication prescription, including beta blockers, calcium channel blockers, angiotensin‐converting enzyme inhibitors, and diuretics, in primary care. Random effects meta‐analysis was used to obtain pooled women‐to‐men prevalence ratios for each cardiovascular medication prescription. Metaregression models assessed the impact of age and year on the findings. A total of 43 studies were included, involving 2 264 600 participants (28% women) worldwide. Participants’ mean age ranged from 51 to 76 years. The pooled prevalence of cardiovascular medication prescription for women was 41% for aspirin, 60% for statins, and 68% for any antihypertensive medications. Corresponding rates for men were 56%, 63%, and 69% respectively. The pooled women‐to‐men prevalence ratios were 0.81 (95% CI, 0.72–0.92) for aspirin, 0.90 (95% CI, 0.85–0.95) for statins, and 1.01 (95% CI, 0.95–1.08) for any antihypertensive medications. Women were less likely to be prescribed angiotensin‐converting enzyme inhibitors (0.85; 95% CI, 0.81–0.89) but more likely with diuretics (1.27; 95% CI, 1.17–1.37). Mean age, mean age difference between the sexes, and year of study had no significant impact on findings. Conclusions Sex differences in the prescription of cardiovascular medication exist among patients at high risk or with established cardiovascular disease in primary care, with a lower prevalence of aspirin, statins, and angiotensin‐converting enzyme inhibitors prescription in women and a lower prevalence of diuretics prescription in men.https://www.ahajournals.org/doi/10.1161/JAHA.119.014742cardiovascular medicationmeta‐analysisprimary caresex differencessystematic review
spellingShingle Min Zhao
Mark Woodward
Ilonca Vaartjes
Elizabeth R. C. Millett
Kerstin Klipstein‐Grobusch
Karice Hyun
Cheryl Carcel
Sanne A. E. Peters
Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta‐Analysis
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
cardiovascular medication
meta‐analysis
primary care
sex differences
systematic review
title Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta‐Analysis
title_full Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta‐Analysis
title_fullStr Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta‐Analysis
title_full_unstemmed Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta‐Analysis
title_short Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta‐Analysis
title_sort sex differences in cardiovascular medication prescription in primary care a systematic review and meta analysis
topic cardiovascular medication
meta‐analysis
primary care
sex differences
systematic review
url https://www.ahajournals.org/doi/10.1161/JAHA.119.014742
work_keys_str_mv AT minzhao sexdifferencesincardiovascularmedicationprescriptioninprimarycareasystematicreviewandmetaanalysis
AT markwoodward sexdifferencesincardiovascularmedicationprescriptioninprimarycareasystematicreviewandmetaanalysis
AT iloncavaartjes sexdifferencesincardiovascularmedicationprescriptioninprimarycareasystematicreviewandmetaanalysis
AT elizabethrcmillett sexdifferencesincardiovascularmedicationprescriptioninprimarycareasystematicreviewandmetaanalysis
AT kerstinklipsteingrobusch sexdifferencesincardiovascularmedicationprescriptioninprimarycareasystematicreviewandmetaanalysis
AT karicehyun sexdifferencesincardiovascularmedicationprescriptioninprimarycareasystematicreviewandmetaanalysis
AT cherylcarcel sexdifferencesincardiovascularmedicationprescriptioninprimarycareasystematicreviewandmetaanalysis
AT sanneaepeters sexdifferencesincardiovascularmedicationprescriptioninprimarycareasystematicreviewandmetaanalysis